Skip to content

Clinical trials

Terminated Phase 2 Autoimmune Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 2 Status: Terminated Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20081
20112
20131
20171
20191
20202
20212
20223
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Immunovant Sciences GmbH2
Novartis Pharmaceuticals2
Alkahest, Inc.1
Amgen1
Emory University1
Human Genome Sciences Inc.1
Imcyse SA1
Lakefront Biotherapeutics NV1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases17
Sjogren's Syndrome4
Immune System Diseases3
Lupus Erythematosus, Systemic3
Multiple Sclerosis3
Rheumatic Diseases3
Arthritis2
Arthritis, Rheumatoid2
Connective Tissue Diseases2
Diabetes Mellitus, Type 12

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.